Chief Commercial Officer · Guardant Health, Inc. · Common Stock
Side
SELL
Value
$48K
Shares
478
Price
$101.43
Executed
Dec 5, 2025
Disclosed
Dec 8, 2025
Disclosure timeline3 days from execution to publication · legal deadline 2 business days
Dec 5 executedDec 8, 2025 disclosed
GH · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+15 / 15
6 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Freeman Chris filed this Form 4 reporting a open-market sale of GH on Dec 5, 2025. It became public on Dec 8, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Commercial Officer
Freeman Chriscik:0001871615
Issuer
Guardant Health, Inc.cik:0001576280
Revision history · 0
No field has changed since this record was first ingested.
